glp-1 news september 26 2025 GLP-1s and AI tools: 2025's biggest health stories glp-1 agonist side effects wellness Quantity:Monthly

glp-1 news september 26 2025 GLP-1s and AI tools: 2025's biggest health stories glp-1 agonist side effects wellness Quantity:Monthly

glp-1 agonist side effects fatigue Pharmacovigilance analysis of neurological adverse events associated with receptor agonists based on the FDA ...

In the STEP-9 trial, use of semaglutide led to greater weight loss and improvements in knee pain and physical function compared to placebo in patients with obesity and moderate-to-severe osteoarthritis-related symptoms

wellness

Quantity:Monthly

Key Regions and Countries North America US Canada Europe Germany France The UK Spain Italy Russia Netherland Rest of Europe Asia Pacific China Japan South Korea India Australia New Zealand Singapore Thailand Vietnam Rest of APAC Latin America Brazil Mexico Rest of Latin America Middle East & Africa South Africa Saudi Arabia UAE Rest of MEA Key Players Analysis Key players in the GLP-1 Receptor Agonist Market are characterized by their strong research and development capabilities, extensive product portfolios, and global presence